NCT06179810

Brief Summary

Pre/posttest randomized control trial design. In this study all patients will be randomly assigned into two groups (30 in each group) :

  • Group A will do baduanjin exercise in addition to traditional medical treatment.
  • Group B will take traditional medical treatment only.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 15, 2023

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

December 12, 2023

Completed
3 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

December 22, 2023

Completed
Last Updated

December 22, 2023

Status Verified

December 1, 2023

Enrollment Period

7 months

First QC Date

December 12, 2023

Last Update Submit

December 12, 2023

Conditions

Metabolic Syndrome

Outcome Measures

Primary Outcomes (2)

  • Fasting glucose level

    Pre/post fasting glucose level in blood

    3 months

  • Lipids profile

    Pre/post HDL \& lDL levels in blood

    3 months

Study Arms (2)

Baduanjin exercise in addition to medical treatment

EXPERIMENTAL

30 patients with metabolic syndrome do baduanjin exercise in addition to traditional medical treatment

Other: Baduanjin exercise

Traditional medical treatment

EXPERIMENTAL

30 patients with metabolic syndrome taking traditional medical treatment

Other: Baduanjin exercise

Interventions

Baduanjin exerciseOTHER

Baduanjin exercise

Baduanjin exercise in addition to medical treatmentTraditional medical treatment

Eligibility Criteria

Age60 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • metabolic syndrome patients

You may not qualify if:

  • patients with Respiratory diseases
  • patients with pacemaker patients
  • patients with Neurological diseases
  • patients with orthopedic diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ahmed Mohamed Abdelrahman Eldeeb

Cairo, Qaliop Elbalad, Egypt

RECRUITING

MeSH Terms

Conditions

Metabolic Syndrome

Condition Hierarchy (Ancestors)

Insulin ResistanceHyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Central Study Contacts

Ahmed Mohamed Eldeeb, Master

CONTACT

01153278847eldeebahmed2018@gmail.com

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Pre/posttest randomized control trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
EFFECT OF BADUANJIN EXERCISE ON QUALITY OF LIFE IN PATIENTS WITH METABOLIC SYNDROME

Study Record Dates

First Submitted

December 12, 2023

First Posted

December 22, 2023

Study Start

May 15, 2023

Primary Completion

December 15, 2023

Study Completion

December 15, 2023

Last Updated

December 22, 2023

Record last verified: 2023-12

Locations

EG(1)